Report: Global E-Prescribing Market to Reach Nearly $900M by 2019 | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Report: Global E-Prescribing Market to Reach Nearly $900M by 2019

November 9, 2016
by Rajiv Leventhal
| Reprints

The global e-prescribing market is expected to grow at a compound annual growth rate (CAGR) of 23.5 percent from 2013 to 2019, to reach an estimated value of $888 million in 2019.

The new market report, published by Persistence Market Research “Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019,” noted that the global e-prescribing market was valued at $250 million in 2013. Indeed, the electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets, has continued to increase throughout healthcare.

In some states, there are e-prescribing mandates, as regulators say that it provides for a safer and more convenient way of ensuring that a prescription reaches a pharmacy, thus reducing medical errors in effect. And, according to this report, the e-prescribing market is witnessing a significant growth led by various government programs to implement e-prescribing systems in order to improve the quality of healthcare and reduce medication errors. “E-prescribing systems are used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data,” the report found.

Additionally, improved healthcare infrastructure has increased the demand for e-prescribing system, according to the report. Moreover, implementation of electronic healthcare records (EHRs) with e-prescribing system holds great potential for the growth of e-prescribing market, the report stated. Nonetheless, the high cost of e-prescribing systems and the lack of patient privacy and security impede growth of the market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the e-prescribing market, according to the report.

While Europe holds the largest share in e-prescribing market, the U.S. was found to be the market’s fastest growing region, globally. Henry Schein, Inc. and Cerner Corporation are the major leading players in the global e-prescribing market, according to the report.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.